1. Health-related quality of life in primary hepatic cancer: a systematic review assessing the methodological properties of instruments and a meta-analysis comparing treatment strategies
- Author
-
Pascal Probst, Christoph Engel, Kerstin Wohlleber, Patrick Heger, Markus K. Diener, and André L. Mihaljevic
- Subjects
Quality of life ,medicine.medical_specialty ,Psychometrics ,Hepatocellular carcinoma ,Health-related quality of life ,Health Status ,MEDLINE ,CINAHL ,PsycINFO ,Cholangiocellular carcinoma ,Cochrane Library ,Article ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Patient Reported Outcome Measures ,business.industry ,Public health ,Liver Neoplasms ,Public Health, Environmental and Occupational Health ,Cancer ,medicine.disease ,humanities ,030220 oncology & carcinogenesis ,Meta-analysis ,Physical therapy ,030211 gastroenterology & hepatology ,business - Abstract
Purpose Patient-reported outcomes including health-related quality of life (HRQoL) are important oncological outcome measures. The validation of HRQoL instruments for patients with hepatocellular and cholangiocellular carcinoma is lacking. Furthermore, studies comparing different treatment options in respect to HRQoL are sparse. The objective of the systematic review and meta-analysis was, therefore, to identify all available HRQoL tools regarding primary liver cancer, to assess the methodological quality of these HRQoL instruments and to compare surgical, interventional and medical treatments with regard to HRQoL. Methods A systematic literature search was conducted in MEDLINE, the Cochrane library, PsycINFO, CINAHL and EMBASE. The methodological quality of all identified HRQoL instruments was performed according to the COnsensus-based Standards for the selection of health status Measurements INstruments (COSMIN) standard. Consequently, the quality of reporting of HRQoL data was assessed. Finally, wherever possible HRQoL data were extracted and quantitative analyses were performed. Results A total of 124 studies using 29 different HRQoL instruments were identified. After the methodological assessment, only 10 instruments fulfilled the psychometric criteria and could be included in subsequent analyses. However, quality of reporting of HRQoL data was insufficient, precluding meta-analyses for 9 instruments. Conclusion Using a standardized methodological assessment, specific HRQoL instruments are recommended for use in patients with hepatocellular and cholangiocellular carcinoma. HRQoL data of patients undergoing treatment of primary liver cancers are sparse and reporting falls short of published standards. Meaningful comparison of established treatment options with regard to HRQoL was impossible indicating the need for future research.
- Published
- 2021
- Full Text
- View/download PDF